Moleculin Biotech (NASDAQ:MBRX) & Ardelyx (NASDAQ:ARDX) Head-To-Head Survey
Moleculin Biotech (NASDAQ:MBRX – Get Free Report) and Ardelyx (NASDAQ:ARDX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations. Risk & Volatility Moleculin Biotech has a beta […]
More Stories
Western Asset Inflation-Linked Opportunities & Income Fund (WIW) to Issue Monthly Dividend of $0.06 on December 31st
Western Asset Inflation-Linked Opportunities & Income Fund (NYSE:WIW – Get Free Report) announced a monthly dividend on Monday, November 25th,NASDAQ...
Eaton Vance Tax-Managed Diversified Equity Income Fund (ETY) To Go Ex-Dividend on December 23rd
Eaton Vance Tax-Managed Diversified Equity Income Fund (NYSE:ETY – Get Free Report) announced a monthly dividend on Monday, December 2nd,NASDAQ...
Financial Institutions (NASDAQ:FISI) Coverage Initiated by Analysts at Piper Sandler
Piper Sandler initiated coverage on shares of Financial Institutions (NASDAQ:FISI – Free Report) in a research note released on Friday...
Radian Group Inc. (NYSE:RDN) Enters into Amendment to Master Repurchase Agreement with JPMorgan
Radian Group Inc., a financial services company based in Wayne, Pennsylvania, made public a significant development on December 13, 2024,...
FuelCell Energy (NASDAQ:FCEL) Price Target Raised to $12.00 at TD Cowen
FuelCell Energy (NASDAQ:FCEL – Free Report) had its price objective boosted by TD Cowen from $2.00 to $12.00 in a...
Arrow Financial (NASDAQ:AROW) Now Covered by Analysts at Piper Sandler
Piper Sandler initiated coverage on shares of Arrow Financial (NASDAQ:AROW – Free Report) in a research report released on Friday...